As COVID-19 vaccines are being rolled out, the deep fault lines in our global health system are growing more apparent. Despite commitments to global action, developed nations have bought up nearly all available vaccines. In addition to the moral failings of this approach, it has profound consequences for our global recovery.
Join us as a panel of experts discuss the challenges of global vaccine access and what a healthier path for all would entail.
Dr. Ana Céspedes, Chief Operating Officer, IAVI
Dr. Ana Céspedes is Chief Operating Officer of IAVI, a global organization based in New York, dedicated to developing globally affordable and accessible vaccines and antibodies for HIV, TB and COVID-19, among other infectious diseases.
Previously, Dr. Céspedes has held numerous positions of responsibility in health consulting and in the Biotechnology and Pharmaceutical Industries in Europe, US and worldwide, in the areas of Communication, Government Affairs, Regulatory Affairs, Pricing and Market Access, Marketing and Strategy, and General Management. She is a Doctor in Pharmacy Magna Cum Laude and Extraordinary Award; Master in Management of Health Institutions; Trained in strategy in the biomedical area by the London School of Economics; Executive Degree in General Management from IESE; formed in Breakthrough Leadership by GAP International and Certified in Business Innovation by the Massachusetts Institute of Technology (MIT).
Dr. Mohga Kamal-Yanni MPhil. MBE, Global Health & Access to Medicines Consultant
Dr. Mohga Kamal-Yanni is a Global Health & Access to Medicines Consultant and Senior health advisor with 40 years of experience in health policy and programming with international and national development agencies including NGOs and governments in developing countries in Africa, Asia, Latin America, and Eastern Europe.
She is currently providing technical and policy support to UNAIDS and the People Vaccine Alliance on access to Covid-19 health technology and a key advisor to the NGO board members to UNITAID.
Dr. Kamal-Yanni also has a broad experience engaging with most international organizations related to health: WHO, Global Fund including the Market Dynamic Committee, UNITAID, Medicine Patent Pool and the World bank.
Dr. Nolan Ritcey, VP Impact Research, Domini
Dr. Nolan Ritcey, PhD is Vice President - Impact Research at Domini Impact Investments LLC, where he leads research in the health care sector and covers companies in industrials, materials, and information technology sectors.
Prior to joining Domini in 2018, Dr. Ritcey was Assistant Director of Research at Bioethics International, a health care research non-profit focused on data transparency in clinical research, and worked for proxy advisor Glass Lewis & Co. on their research and engagement teams.
Dr. Ritcey completed his PhD in philosophical ethics at Queens University (Canada), where he was a Social Science Research Council of Canada Doctoral Fellow and a Visiting Research Scholar at University of California, Berkeley. He also holds an M.A. from the University of Victoria (Canada) and a B.A. (hons) from Dalhousie University.
Corey Klemmer, Director of Engagement, Domini.
Corey Klemmer’s diverse experience with law, financial analysis, corporate engagements and issue-based organizing enables her to lead Domini’s efforts as a voice for change. She is responsible for leading Domini’s engagement efforts with portfolio companies and broader stakeholder groups, as well as developing initiatives and campaigns.
Prior to joining Domini, Corey served as an analyst at the AFL-CIO Office of Investment where she worked with pension funds, policy makers and other stakeholders to advocate for forward-thinking investor perspectives on many issues including systemic risk, human capital management, student debt, criminal justice reform, and corporate disclosure reform. Her legal background includes work with the Strategic Counsel for Corporate Sustainability, The Initiative for Responsible Investment and her work as an attorney at The Lambert Firm prior to joining AFL-CIO.
Corey graduated cum laude from Amherst College with a B.A. in Law, Jurisprudence and Social Thought and earned her J.D. from Tulane University Law School.